This Pre-Solicitation opportunity was posted on October 22, 2012. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
65--618-13-1-4005-0002 - Radiopharmeceuticals
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract, identified as 65-618-13-1-4005-0002, is an award for the procurement of radiopharmaceuticals under solicitation VA26313R1484. The agreement began with a base year running from October 1, 2013, through September 30, 2014, with an estimated base value of 580,993.00 dollars. The total estimated value for the base year period was initially listed at 3,094,013.60 dollars. The contract structure includes four optional extension years that the government may exercise at its sole discretion. These options run annually from October 1, 2014, through September 30, 2018, with estimated costs increasing each year from 600,743.76 dollars in the first option year to 656,403.70 dollars in the fourth. All inquiries regarding this award are directed to Jim McDavitt.
General Info
Agency
Contract Value
$0Place of Performance
USASet-Aside
Awardee
TRIAD ISOTOPES, INC.Award Issued Date
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
